Timely remdesivir treatment in immunocompromised patients infected with COVID-19 is associated with improved survival outcomes.
Cancer patients may require COVID-19 vaccinations more often than the general public, but guidance is needed, researchers say.
Prevalence rates for early childhood asthma in the United States show marked racial/ethnic and socio-economic disparities that taper with age.
In COPD, respiratory morbidity and mortality are associated with airway luminal narrowing, a change that can be measured.
Children with health care-associated vs nonhealth care-associated RSV were more likely to require escalation of respiratory support.
Baricitinib is an effective treatment option for children and adolescents with atopic dermatitis, with no new safety signals identified.
Upadacitinib was superior to dupilumab for the treatment of atopic dermatitis in the head and neck, trunk, upper limbs, and lower limbs.
Remdesivir treatment reduces the risk for 30-day COVID-19-related hospital readmission among all patients discharged alive from initial hospitalization.
Patients with CRSwNP have a high burden of SCS use and associated health care costs, especially when they have comorbid asthma.
Using GLI Global vs GLI Caucasian spirometry equations in pediatric patients aged 18 and younger was linked to significant changes in z-scores.
Results of a small study suggest similar pathophysiology of cognitive dysfunction and neuropathic pain in patients with long COVID.
The 2025 GOLD COPD report has a new emphasis on CV disease and PH in COPD and major updates on new drugs, climate change, and ...